These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 38555441)

  • 21. Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli.
    Silva F; Queiroz JA; Domingues FC
    Biotechnol Adv; 2012; 30(3):691-708. PubMed ID: 22244816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the effect of expression of an acetyl-CoA synthetase insensitive to acetylation on co-utilization of glucose and acetate in batch and continuous cultures of E. coli W.
    Novak K; Flöckner L; Erian AM; Freitag P; Herwig C; Pflügl S
    Microb Cell Fact; 2018 Jul; 17(1):109. PubMed ID: 29986728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems metabolic engineering of Escherichia coli for the heterologous production of high value molecules-a veteran at new shores.
    Becker J; Wittmann C
    Curr Opin Biotechnol; 2016 Dec; 42():178-188. PubMed ID: 27513555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered polyketide biosynthesis and biocatalysis in Escherichia coli.
    Gao X; Wang P; Tang Y
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1233-42. PubMed ID: 20853106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a 3-hydroxypropionate resistant Escherichia coli strain.
    Liu M; Han X; Xian M; Ding Y; Liu H; Zhao G
    Bioengineered; 2016; 7(1):21-7. PubMed ID: 26709549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic flux analysis of Escherichia coli knockouts: lessons from the Keio collection and future outlook.
    Long CP; Antoniewicz MR
    Curr Opin Biotechnol; 2014 Aug; 28():127-33. PubMed ID: 24686285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic engineering for high yielding L(-)-carnitine production in Escherichia coli.
    Arense P; Bernal V; Charlier D; Iborra JL; Foulquié-Moreno MR; Cánovas M
    Microb Cell Fact; 2013 May; 12():56. PubMed ID: 23718679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogen production by recombinant Escherichia coli strains.
    Maeda T; Sanchez-Torres V; Wood TK
    Microb Biotechnol; 2012 Mar; 5(2):214-25. PubMed ID: 21895995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the heterologous metabolism supporting 6-deoxyerythronolide B biosynthesis in Escherichia coli.
    Zhang H; Wang Y; Boghigian B; Pfeifer BA
    Microb Biotechnol; 2009 May; 2(3):390-4. PubMed ID: 21261933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering the Escherichia coli fermentative metabolism.
    Orencio-Trejo M; Utrilla J; Fernández-Sandoval MT; Huerta-Beristain G; Gosset G; Martinez A
    Adv Biochem Eng Biotechnol; 2010; 121():71-107. PubMed ID: 20182928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The essential role of mRNA degradation in understanding and engineering E. coli metabolism.
    Roux C; Etienne TA; Hajnsdorf E; Ropers D; Carpousis AJ; Cocaign-Bousquet M; Girbal L
    Biotechnol Adv; 2022; 54():107805. PubMed ID: 34302931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Continuing Development of E. coli as a Heterologous Host for Complex Natural Product Biosynthesis.
    Zhang H; Fang L; Osburne MS; Pfeifer BA
    Methods Mol Biol; 2016; 1401():121-34. PubMed ID: 26831705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constraint-based modeling of heterologous pathways: application and experimental demonstration for overproduction of fatty acids in Escherichia coli.
    Ip K; Donoghue N; Kim MK; Lun DS
    Biotechnol Bioeng; 2014 Oct; 111(10):2056-66. PubMed ID: 24838438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated production of 3-hydroxypropionic acid by metabolic engineering of the glycerol metabolism in Escherichia coli.
    Jung WS; Kang JH; Chu HS; Choi IS; Cho KM
    Metab Eng; 2014 May; 23():116-22. PubMed ID: 24650754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous production of 3-hydroxyvalerate in engineered Escherichia coli.
    Miscevic D; Srirangan K; Kefale T; Kilpatrick S; Chung DA; Moo-Young M; Chou CP
    Metab Eng; 2020 Sep; 61():141-151. PubMed ID: 31726215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic footprint analysis of recombinant Escherichia coli strains during fed-batch fermentations.
    Carneiro S; Villas-Bôas SG; Ferreira EC; Rocha I
    Mol Biosyst; 2011 Mar; 7(3):899-910. PubMed ID: 21152511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-scale target identification in Escherichia coli for high-titer production of free fatty acids.
    Fang L; Fan J; Luo S; Chen Y; Wang C; Cao Y; Song H
    Nat Commun; 2021 Aug; 12(1):4976. PubMed ID: 34404790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homologous overexpression of RfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide.
    Cimini D; De Rosa M; Carlino E; Ruggiero A; Schiraldi C
    Microb Cell Fact; 2013 May; 12():46. PubMed ID: 23659469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic feedback regulation for efficient membrane protein production using a small RNA-based genetic circuit in Escherichia coli.
    Guidi C; De Wannemaeker L; De Baets J; Demeester W; Maertens J; De Paepe B; De Mey M
    Microb Cell Fact; 2022 Dec; 21(1):260. PubMed ID: 36522655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering the flagellar type III secretion system: improving capacity for secretion of recombinant protein.
    Green CA; Kamble NS; Court EK; Bryant OJ; Hicks MG; Lennon C; Fraser GM; Wright PC; Stafford GP
    Microb Cell Fact; 2019 Jan; 18(1):10. PubMed ID: 30657054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.